Improving systems to track and control drug-resistant gonorrhea in the U.S.
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
This study is looking at how to better track and fight the spread of drug-resistant gonorrhea in the U.S. by figuring out the best places to test for it and how many samples to collect, so we can protect people at higher risk in big cities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10845473 on NIH RePORTER |
What this research studies
This research focuses on enhancing surveillance systems to monitor and combat the spread of antimicrobial-resistant gonorrhea, a significant public health threat in the United States. By developing a simulation model, the project aims to identify optimal locations for surveillance sites and determine how many samples should be tested for drug resistance among different risk groups. The study will analyze data from the 50 most populous metropolitan areas to inform public health strategies and improve response efforts against this infection.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at higher risk for gonorrhea, such as men who have sex with men and women in urban areas.
Not a fit: Patients who are not at risk for gonorrhea or those who do not reside in the targeted metropolitan areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective public health strategies that slow the spread of drug-resistant gonorrhea, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown success in using surveillance systems to track infectious diseases, indicating that this approach has potential for effectiveness.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Yaesoubi, Reza — Yale University
- Study coordinator: Yaesoubi, Reza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.